Knight Therapeutics, Inc. (GUD.TO)
6.00
-0.04
(-0.66%)
CAD |
TSX |
Dec 19, 16:00
Knight Therapeutics Shareholders Equity (Quarterly): 766.79M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Profound Medical Corp. | 44.72M |
| Biocure Technology, Inc. | 1.604M |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.1483M |
| NanoSphere Health Sciences, Inc. | -1.909M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.049B |
| Total Liabilities (Quarterly) | 281.78M |
| Debt to Equity Ratio | 0.1386 |
| Current Ratio | 2.624 |
| Net Debt Paydown Yield | -1.64% |